Literature DB >> 27702689

Screening of soluble epoxide hydrolase inhibitory ingredients from traditional Chinese medicines for anti-inflammatory use.

Jun-Yan Liu1, Christophe Morisseau2, Huazhang Huang2, Bruce D Hammock2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Inhibition of soluble epoxide hydrolase (sEH) has been extensively reported to be anti-inflammatory in multiple animal models. Some anti-inflammatory traditional Chinese medicines (TCMs) and a few natural compounds were also found to be inhibitory to sEH in vitro. AIM OF THE STUDY: To determine whether the active intergradient (AI) against sEH of anti-inflammatory TCMs in vitro is anti-inflammatory in vivo and the sEH inhibitory action of the AI contributes to its anti-inflammatory effect in vivo.
MATERIALS AND METHODS: In vitro inhibition assay of the sEH was conducted for the methanol and ethanol extracts of 27 anti-inflammatory TCMs. Two potent extracts were subject to further separation guided by bioassay to afford promising AI against sEH in vitro [Fr.5 of the crude ethanol extract of Rhizoma coptidis (FFCERC)]. Finally, the in vivo anti-inflammatory effect and sEH inhibitory potency of FFCERC was evaluated in a lipopolysacchride (LPS)-challenged murine model of acute systemic inflammation. The inflammatory status was characterized by the inflammatory cytokines TNF-α and interleukin-6 (IL-6) and sEH inhibitory function was evaluated by the plasma levels of epoxyeicosantrienoic acids (EETs) and dihydroxyeicosatrienoic acids (DHETs), which are the sEH mediated substrates and products, respectively.
RESULTS: At the concentration of 25µg/mL, the crude ethanol extracts of 6 TCMs including Herba Asari, Radix Polygalae, Fructus Amomi, Radix Astragali, Radix Scutellariae, and Rhizoma Coptidis were potent against sEH. The crude extracts of Herba Asari and Rhizoma Coptidis were selected for further separation to afford FFCERC as the most promising AI for in vivo evaluation. Oral administration of FFCERC attenuated the significant increase in TNF-α and IL-6 caused by LPS challenge in a dose-dependent manner. In parallel, oral administration of FFCERC shifted the changes in plasma levels of EETs and DHETs caused by LPS-challenge like a synthetic sEH inhibitor.
CONCLUSIONS: A sEH inhibitory AI from Rhizoma Coptidis is anti-inflammatory and the inhibition of sEH contributes to this biological effect, indicating that sEH may be at least one of multiple therapeutic targets for relevant TCMs.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammation; Cytokines; Eicosanoids; Rhizoma Coptidis; Soluble epoxide hydrolase (sEH)

Mesh:

Substances:

Year:  2016        PMID: 27702689      PMCID: PMC5584568          DOI: 10.1016/j.jep.2016.09.044

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  47 in total

1.  Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.

Authors:  Paul D Jones; Nicola M Wolf; Christophe Morisseau; Paul Whetstone; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

2.  Soluble epoxide hydrolase inhibitory activity of phenolic components from the rhizomes and roots of Gentiana scabra.

Authors:  Wei Li; Jang Hoon Kim; Wei Zhou; Sang Hee Shim; Jin Yeul Ma; Young Ho Kim
Journal:  Biosci Biotechnol Biochem       Date:  2015-01-15       Impact factor: 2.043

3.  Coptis chinensis Franch. exhibits neuroprotective properties against oxidative stress in human neuroblastoma cells.

Authors:  Thomas Friedemann; Benjamin Otto; Kristin Klätschke; Udo Schumacher; Yi Tao; Alexander Kai-Man Leung; Thomas Efferth; Sven Schröder
Journal:  J Ethnopharmacol       Date:  2014-06-12       Impact factor: 4.360

4.  Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.

Authors:  Yingmei Liu; Heather K Webb; Hisayo Fukushima; Janine Micheli; Svetlana Markova; Jean L Olson; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2012-03-13       Impact factor: 4.030

5.  Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.

Authors:  Padmini Sirish; Ning Li; Jun-Yan Liu; Kin Sing Stephen Lee; Sung Hee Hwang; Hong Qiu; Cuifen Zhao; Siu Mei Ma; Javier E López; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

6.  Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.

Authors:  Guodong Zhang; Dipak Panigrahy; Lisa M Mahakian; Jun Yang; Jun-Yan Liu; Kin Sing Stephen Lee; Hiromi I Wettersten; Arzu Ulu; Xiaowen Hu; Sarah Tam; Sung Hee Hwang; Elizabeth S Ingham; Mark W Kieran; Robert H Weiss; Katherine W Ferrara; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

Review 7.  Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.

Authors:  Jun Tang; Yibin Feng; Saiwah Tsao; Ning Wang; Robert Curtain; Youwei Wang
Journal:  J Ethnopharmacol       Date:  2009-08-15       Impact factor: 4.360

Review 8.  The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.

Authors:  Ingrid Fleming
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 9.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  UPLC-QTOF/MS Analysis of Alkaloids in Traditional Processed Coptis chinensis Franch.

Authors:  Xue Jiang; Lin-Fang Huang; La-Bin Wu; Zeng-Hui Wang; Shi-Lin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-13       Impact factor: 2.629

View more
  5 in total

Review 1.  Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.

Authors:  Amarjyoti Das Mahapatra; Rinku Choubey; Bhaskar Datta
Journal:  Molecules       Date:  2020-11-24       Impact factor: 4.411

2.  Detoxification II Prescription Suppresses the Th-17/IL-17 Inflammatory Axis to Improve the Liver Function of ACLF-Rats via Inactivating the P38MAPK Pathway.

Authors:  Qinglan Shi; Wenjie Bai; Dewen Mao; Yueqiao Chen; Kejing Wang; Hua Qiu; Jinyu Wu
Journal:  J Healthc Eng       Date:  2021-12-03       Impact factor: 2.682

Review 3.  Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review.

Authors:  Pei Teng Lum; Mahendran Sekar; Siew Hua Gan; Srikanth Jeyabalan; Srinivasa Reddy Bonam; Nur Najihah Izzati Mat Rani; Ku-Marina Ku-Mahdzir; Lay Jing Seow; Yuan Seng Wu; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Saudi J Biol Sci       Date:  2021-11-16       Impact factor: 4.219

4.  Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase.

Authors:  Jang Hoon Kim; Chong Woon Cho; Mok Hur; Woo Tae Park; Youn-Ho Moon; Sung-Cheol Koo; Yun-Chan Hur; Jong Seong Kang; Ik Soo Lee
Journal:  Curr Issues Mol Biol       Date:  2022-09-16       Impact factor: 2.976

5.  Identification of a Multicomponent Traditional Herbal Medicine by HPLC-MS and Electron and Light Microscopy.

Authors:  Ju-Han Liu; Yung-Yi Cheng; Chen-Hsi Hsieh; Tung-Hu Tsai
Journal:  Molecules       Date:  2017-12-15       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.